Primus Pharmaceuticals, Inc. recalls Limbrel — Limbrel, Limbrel 250, Limbrel 500
- Recall date
- January 29, 2018
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Primus Pharmaceuticals, Inc., Limbrel
Why it was recalled
Due to adverse event reports of elevated liver function tests or acute hypersensitivity pneumonitis — Device & Drug Safety
What was recalled
Limbrel, Limbrel 250, Limbrel 500
Read the official recall notice →
Get recall alerts
Free email alert whenever Primus Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Primus Pharmaceuticals, Inc., Limbrel